Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology
NCT06856525
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
A two-center, longitudinal assessment of 40 electronic cigarette users and 40 healthy controls at the initial visit and a follow-up visit 12 months later. This study will determine the impact of electronic cigarette use on pulmonary gas exchange capacity and then corroborate the Hyperpolarized Xenon MRI (HXeMRI) results with the cardiopulmonary stress test at the initial visit and a follow-up visit 12 months later.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Electronic Cigarette Related Lung Damage
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2/3
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Y. Michael Shim, MD
- Last updated on ClinicalTrials.gov
- March 17, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 1
- Duke University · Durham, NC
Virginia · 1
- University of Virginia · Charlottesville, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.